POST-COVID SYNDROME: MULTISYSTEM IMPACTS AND INTEGRATIVE MANAGEMENT APPROACHES

Rachel Joyceline

Authors

Rachel Joyceline Department of Primary Health Care, Jumuia Hospital Huruma, Johnsaga, Nairobi, Kenya.

Keywords:

Post-covid Syndrome, Long Covid, Multisystem Impacts, Management Approaches.

Abstract

Long COVID, also called post-COVID syndrome, occurs in 10-30% of SARS-CoV-2 survivors and makes its presence felt in 5 to 10 organ systems as it persists in effect long after initial infections, causing considerable damage to quality of life. This systematic review was conducted based on published research from 2020 to 2025, including the pathophysiology, clinical presentation, and integrative management of Long COVID. We discuss its effects on the respiratory and cardiovascular system, as well as the neurological, psychological, and gastrointestinal system, and its mechanisms, namely, immune dysregulation, microvascular dysfunction, chronic inflammation, and mitochondrial dysfunction. The drug treatments, multidisciplinary rehabilitation, and lifestyle changes are assessed regarding their efficacy, availability, and shortcomings. Such issues as diagnostic uncertainty, healthcare disparity, and the lack of standardized protocols are highly evaluated, and future research priorities on these gaps are observed. Based on 25 peer-reviewed articles, this article offers a concise outline of the issues related to Long COVID care that include presenting standardized instructions, interdisciplinary cooperation, and innovative technologies to clinicians and researchers.

References

World Health Organization. Expanding our understanding of post-COVID-19 condition: report of a WHO webinar, 9 February 2021. World Health Organization; 2021. https://books.google.com.ng/books?id=1HcOEQAAQBAJ

Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374:n1648. https://doi.org/10.1136/bmj.n1648

Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms, and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. https://doi.org/10.1038/s41579-022-00846-2

Moretti C, Barker KK. Suffering without Remedy: The Medically Unexplained Symptoms of Fibromyalgia Syndrome and Long COVID. Social Sciences. 2024; 13(9):450. https://doi.org/10.3390/socsci13090450

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71

Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-264. https://doi.org/10.1038/s41586-021-03553-9

Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27(4):328–337. https://doi.org/10.1016/j.pulmoe.2020.10.013

Daynes E, Baldwin M, Greening NJ, et al. The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium. Trials. 2023;24(1):61. https://doi.org/10.1186/s13063-023-07093-7

Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol (1985). 2021;130(5):1470–1478. https://doi.org/10.1152/japplphysiol.00710.2020

Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69(2):205–211. https://doi.org/10.1007/s12026-021-09185-5

Sanghvi SK, Schwarzman LS, Nazir NT. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics (Basel). 2021;11(1):130. https://doi.org/10.3390/diagnostics11010130

Koutsiaris AG, Karakousis K. Long COVID Mechanisms, Microvascular Effects, and Evaluation Based on Incidence. Life (Basel). 2025;15(6):887. https://doi.org/10.3390/life15060887

Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. https://doi.org/10.1016/j.eclinm.2021.101044

Rinaldi V, Bellucci G, Buscarinu MC, Reniè R, Marrone A, Nasello M, et al. CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review. Front Neurol. 2022;13:1018785. https://doi.org/10.3389/fneur.2022.1018785

Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, et al. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1146. https://doi.org/10.1212/NXI.0000000000001146

Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135. https://doi.org/10.1016/j.bbi.2021.12.020

O'Kelly B, Vidal L, McHugh T, Woo J, Avramovic G, Lambert JS. Safety and efficacy of low-dose naltrexone in a long COVID cohort; an interventional pre-post study. Brain Behav Immun Health. 2022;24:100485. https://doi.org/10.1016/j.bbih.2022.100485

Fernández-de-Las-Peñas C, Gómez-Mayordomo V, de-la-Llave-Rincón AI, Palacios-Ceña M, Rodríguez-Jiménez J, Florencio LL, et al. Anxiety, depression, and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study. J Infect. 2021;83(4):496–522. https://doi.org/10.1016/j.jinf.2021.06.022

Ancona G, Alagna L, Alteri C, Palomba E, Tonizzo A, Pastena A, et al. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front Immunol. 2023;14:1080043. https://doi.org/10.3389/fimmu.2023.1080043

Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751–764. https://doi.org/10.1038/s41581-021-00452-0

Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374:n1648. https://doi.org/10.1136/bmj.n1648

Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210–216. https://doi.org/10.1038/s41590-021-01113-x

Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and Its Management. Int J Biol Sci. 2022;18(12):4768–4780. https://doi.org/10.7150/ijbs.75056

Thapaliya K, Marshall-Gradisnik S, Barth M, Eaton-Fitch N, Barnden L. Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients. Front Neurosci. 2023;17:1125208. https://doi.org/10.3389/fnins.2023.1125208

Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U S A. 2021;118(34):e2024358118. https://doi.org/10.1073/pnas.2024358118